Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Emeryville, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Estrella Immunopharma, Inc. has filed 254 SEC EDGAR filings since 19 Feb 2021

SEC filing history

Showing 101-125 of 254 matching filings.

Per page
25
Current page
5
3

3 filing

Filing date
10 Oct 2023
Reporting date
29 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Oct 2023
Reporting date
29 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
25-NSE File 333-253322

25-NSE filing

Filing date
05 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Oct 2023
Reporting date
29 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Oct 2023
Reporting date
29 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Oct 2023
Reporting date
29 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Oct 2023
Reporting date
29 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Oct 2023
Reporting date
29 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Oct 2023
Reporting date
29 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Oct 2023
Reporting date
29 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-40608

CURRENT REPORT

Filing date
20 Sep 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40608

CURRENT REPORT

Filing date
20 Sep 2023
Reporting date
14 Sep 2023
Next action
Verify source filing
425 File 001-40608

CURRENT REPORT

Filing date
18 Sep 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40608

CURRENT REPORT

Filing date
18 Sep 2023
Reporting date
18 Sep 2023
Next action
Verify source filing
425 File 001-40608

CURRENT REPORT

Filing date
18 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40608

CURRENT REPORT

Filing date
18 Aug 2023
Reporting date
18 Aug 2023
Next action
Verify source filing
10-Q File 001-40608

QUARTERLY REPORT

Filing date
01 Aug 2023
Reporting date
30 Jun 2023
Next action
Verify source filing
425 File 001-40608

CURRENT REPORT

Filing date
01 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40608

CURRENT REPORT

Filing date
01 Aug 2023
Reporting date
31 Jul 2023
Next action
Verify source filing
DEFA14A File 001-40608

DEFINITIVE ADDITIONAL MATERIALS

Filing date
26 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-40608

CURRENT REPORT

Filing date
26 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40608

CURRENT REPORT

Filing date
26 Jul 2023
Reporting date
25 Jul 2023
Next action
Verify source filing
8-K File 001-40608

CURRENT REPORT

Filing date
21 Jul 2023
Reporting date
20 Jul 2023
Next action
Verify source filing
425 File 001-40608

CURRENT REPORT

Filing date
19 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .